Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

6082 ARTÍCULOS , VIENDO DEL 4891 AL 4905

Amyloid fibril polymorphism: Structural mechanisms of assembly and the links to disease

Taylor AIP, Radford SE.

Curr Opin Struct Biol. 2026 Mar 13;98:103245. doi: 10.1016/j.sbi.2026.103245. Online ahead of print.

Beyond the brain barrier: Hybrid nanoparticles orchestrating intelligent neuro-theranostics

Saxena S, Kaur J, Singh TG, Kumar M, Awasthi A.

Adv Colloid Interface Sci. 2026 Oct;356:103954. doi: 10.1016/j.cis.2026.103954. Epub 2026 May 25.

Nrf2-Activating Natural Compounds in Neurodegenerative Diseases: Targeting Oxidative Stress and Protein Aggregation

Chico L, Schirinzi E, Balestrini L, Polzella M, Siciliano G.

Int J Mol Sci. 2026 Feb 5;27(3):1592. doi: 10.3390/ijms27031592.

From epigenetic scripts to kinase signals: linking DOT1L and RIPK1 in the neurobiology of degeneration

Kalra P, Grewal AK, Khan H, Chaturvedi D, Singh TG.

Mol Biol Rep. 2026 May 14;53(1):768. doi: 10.1007/s11033-026-11892-x.

Scn4b Modulates Huntington's Disease Phenotype Severity in vivo

Sathitloetsakun S, Farrell V, Pineda SS, Lee H, Shin JH, Garcia FJ, Linville RM, Kellis M, Alvarez VA, Heiman M.

bioRxiv [Preprint]. 2026 Mar 10:2026.03.08.708251. doi: 10.64898/2026.03.08.708251.

Vasopressin 1a Receptor Antagonists for Pathological Aggression in Neurodegenerative and Other CNS Diseases

Simon NG, Brownstein MJ, Anderson KE, Lu SF, Maibach HT.

Biomedicines. 2026 Apr 14;14(4):889. doi: 10.3390/biomedicines14040889.

Parallel improvement of chorea and antiphospholipid autoimmunity during combination therapy with hydroxychloroquine, belimumab, and glucocorticoids in systemic lupus erythematosus

Asano R, Maesaka H, Yamaguchi S, Okada I, Yamazaki M, Sugishita N, Kawataka M, Kido T, Hounoki H, Kato M.

Mod Rheumatol Case Rep. 2026 Jan 6;10(1):rxag011. doi: 10.1093/mrcr/rxag011.

Nose to Brain Delivery of Curcumin Loaded Therapeutic Nanostructures for Neurodegenerative Diseases

Kalita R, Sarma A, Baruah H, Zaman A, Goswami D.

Biopharm Drug Dispos. 2026 Feb;47(1):12-36. doi: 10.1002/bdd.70021. Epub 2026 Jan 3.

Eye manifestations in Huntington's disease: an update on the potential of ocular biomarkers

Woods WA, Barker RA.

J Neurol. 2026 Jan 8;273(1):68. doi: 10.1007/s00415-025-13600-4.

Relationship Between Regulation of Polysialic Acid Expression and Brain Diseases

Hane M, Abe C, Kitajima K, Sato C.

Adv Exp Med Biol. 2026;1491:43-56. doi: 10.1007/978-3-032-04153-1_5.

Programmed cell death pathways in huntington's disease: spotlight on ferroptosis and pyroptosis

Sharma V, Verma R, Sharma P, Singh TG.

Neurol Sci. 2026 Jan 2;47(1):83. doi: 10.1007/s10072-025-08689-4.

Role of mitochondria in neuronal function and survival in the enteric and central nervous systems

Kural I, M Mombeek LM, Wilson DM 3rd.

Cell Mol Life Sci. 2026 Feb 26;83(1):129. doi: 10.1007/s00018-025-06053-5.

Deep brain stimulation in the management of movement disorders in childhood: a UK-wide cross-sectional study

Lumsden DE, Ramiah R, Smallbone T, Singleton W, Amin S, Perides S, Lumsdon G, Ashida R, Ellenbogen J, Ashkan K, Selway R, Kaminska M, Hasegawa H, Lin JP.

Arch Dis Child. 2026 Jan 19;111(2):147-152. doi: 10.1136/archdischild-2025-328889.

Translational roadmap of BBB-targeted nanoparticle strategies for neuroregenerative therapy in neurodegenerative diseases

Lee S, Lee J, Lee K.

Biomater Sci. 2026 Mar 3;14(5):1206-1218. doi: 10.1039/d5bm01582k.

From Balance to Breakdown: striatal PV interneurons in Huntington's disease and Autism Spectrum Disorder

Thabault M, Galvan L.

Front Cell Neurosci. 2026 Feb 23;20:1717636. doi: 10.3389/fncel.2026.1717636. eCollection 2026.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias